|
|
||||||||
J Thorac Cardiovasc Surg 2004;127:608
© 2004 The American Association for Thoracic Surgery
Letter to the editor |
Vita-Salute University of Milano, IRCCS San Raffaele Hospital, Milano, Italy
| The first 20% of the full text of this article appears below. |
To the Editor:
We read with interest the brief communication of Grayling and Deakin1 describing the methylene blue administration in a patient with refractory hypotension during cardiac surgery. We're currently using this drug for patients with high cardiac
Related Article
J. Thorac. Cardiovasc. Surg. 2004 127: 609.
This article has been cited by other articles:
![]() |
R. G. Williams, G. D. Pearson, R. J. Barst, J. S. Child, P. del Nido, W. M. Gersony, K. S. Kuehl, M. J. Landzberg, M. Myerson, S. R. Neish, et al. Report of the National Heart, Lung, and Blood Institute Working Group on Research in Adult Congenital Heart Disease J. Am. Coll. Cardiol., February 21, 2006; 47(4): 701 - 707. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Shanmugam Vasoplegic syndrome--the role of methylene blue Eur J Cardiothorac Surg, November 1, 2005; 28(5): 705 - 710. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |